Preserved microcirculatory response to acute estrogen not reflected by exercise capacity

References

• Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998; 280: 605–13
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321–33
   PubMed Web of Science ®Google Scholar
• Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004; 291: 1701–12
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E, Miller V. Estrogens, lipids, and heart disease. Clin Geriatr Med 1993; 9: 57–67
   PubMedGoogle Scholar
• Keaney JF, Jr, Shwaery GT, Xu A, Nicolosi RJ, Loscalzo J, Foxall TL, et al. 17beta-estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine. Circulation 1994; 89: 2251–9
   PubMed Web of Science ®Google Scholar
• Juan SH, Chen JJ, Chen CH, Lin H, Cheng CF, Liu JC, et al. 17beta-estradiol inhibits cyclic strain-induced endothelin-1 gene expression within vascular endothelial cells. Am J Physiol Heart Circ Physiol 2004; 287: H1254–61
   PubMed Web of Science ®Google Scholar
• al-Khalili F, Landgren BM, Eksborg S, Franco-Cereceda A, Schenck-Gustafsson K. Does sublingual 17 beta-oestradiol have any effects on exercise capacity and myocardial ischaemia in post-menopausal women with stable coronary artery disease?. Eur Heart J 1998; 19: 1019–26
   PubMed Web of Science ®Google Scholar
• Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999; 340: 1801–11
   PubMed Web of Science ®Google Scholar
• Mendelsohn ME. Genomic and nongenomic effects of estrogen in the vasculature. Am J Cardiol ; : F 2002; 90: 3F–6
   PubMed Web of Science ®Google Scholar
• Rosano GM, Sarrel PM, Poole-Wilson PA, Collins P. Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet 1993; 342: 133–6
   PubMed Web of Science ®Google Scholar
• Fagrell B, Jorneskog G, Intaglietta M. Disturbed microvascular reactivity and shunting-a major cause for diabetic complications. Vasc Med 1999; 4: 125–7
   PubMed Web of Science ®Google Scholar
• Zimny S, Dessel F, Ehren M, Pfohl M, Schatz H. Early detection of microcirculatory impairment in diabetic patients with foot at risk. Diabetes Care 2001; 24: 1810–4
   PubMed Web of Science ®Google Scholar
• Stokes KY, Cooper D, Tailor A, Granger DN. Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide. Free Radic Biol Med 2002; 33: 1026–36
   PubMed Web of Science ®Google Scholar
• Kelm M, Preik M, Hafner DJ, Strauer BE. Evidence for a multifactorial process involved in the impaired flow response to nitric oxide in hypertensive patients with endothelial dysfunction. Hypertension 1996; 27: 346–53
   PubMed Web of Science ®Google Scholar
• Rossi M, Cupisti A, Mariani S, Santoro G, Pentimone F. Endothelium-dependent and endothelium-independent skin vasoreactivity in the elderly. Aging Clin Exp Res 2002; 14: 343–6
   PubMed Web of Science ®Google Scholar
• Ijzerman RG, Serne EH, van Weissenbruch MM, de Jongh RT, Stehouwer CD. Cigarette smoking is associated with an acute impairment of microvascular function in humans. Clin Sci (Lond) 2003; 104: 247–52
   PubMed Web of Science ®Google Scholar
• Reis SE, Gloth ST, Blumenthal RS, Resar JR, Zacur HA, Gerstenblith G, et al. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 1994; 89: 52–60
   PubMed Web of Science ®Google Scholar
• Gilligan, DM, Quyyumi, AA, Cannon, RO, 3rd. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 1994;89:2545––51.
   PubMed Web of Science ®Google Scholar
• Gilligan, DM, Badar, DM, Panza, JA, Quyyumi, AA, Cannon, RO, 3rd. Acute vascular effects of estrogen in postmenopausal women. Circulation 1994;90:786––91.
   PubMed Web of Science ®Google Scholar
• Lieberman EH, Gerhard MD, Uehata A, Walsh BW, Selwyn AP, Ganz P, et al. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med 1994; 121: 936–41
   PubMed Web of Science ®Google Scholar
• Collins P, Rosano GM, Sarrel PM, Ulrich L, Adamopoulos S, Beale CM, et al. 17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation 1995; 92: 24–30
   PubMed Web of Science ®Google Scholar
• Guetta, V, Quyyumi, AA, Prasad, A, Panza, JA, Waclawiw, M, Cannon, RO, 3rd. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women. Circulation 1997;96:2795––801.
   PubMed Web of Science ®Google Scholar
• Garcia-Fernandez R, Perez-Velasco JG, Concepcion-Millan A, Sosa S, Navaroli F, Garcia-Barreto D. Estrogen does not prevent endothelial dysfunction caused by cigarette smoking. Clin Cardiol 2004; 27: 71–3
   PubMed Web of Science ®Google Scholar
• Reis SE. Oestrogens attenuate abnormal coronary vasoreactivity in postmenopausal women. Ann Med 1994; 26: 387–8
   PubMed Web of Science ®Google Scholar
• Chambliss KL, Shaul PW. Estrogen modulation of endothelial nitric oxide synthase. Endocr Rev 2002; 23: 665–86
   PubMed Web of Science ®Google Scholar
• Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002–12
   PubMed Web of Science ®Google Scholar
• Holdright DR, Sullivan AK, Wright CA, Sparrow JL, Cunningham D, Fox KM. Acute effect of oestrogen replacement therapy on treadmill performance in postmenopausal women with coronary artery disease. Eur Heart J 1995; 16: 1566–70
   PubMed Web of Science ®Google Scholar
• Davis SR, Bradbury J, Bell R, Johns JA. Acute administration of conjugated equine oestrogen does not improve exercise-induced myocardial ischaemia in men with coronary artery disease. Intern Med J 2003; 33: 221–4
   PubMed Web of Science ®Google Scholar
• Tune JD, Richmond KN, Gorman MW, Feigl EO. Control of coronary blood flow during exercise. Exp Biol Med (Maywood) 2002; 227: 238–50
   PubMed Web of Science ®Google Scholar
• Campisi R, Nathan L, Pampaloni MH, Schoder H, Sayre JW, Chaudhuri G, et al. Noninvasive assessment of coronary microcirculatory function in postmenopausal women and effects of short-term and long-term estrogen administration. Circulation 2002; 105: 425–30
   PubMed Web of Science ®Google Scholar